HAZARDOUS MEDICINES IN A PAEDIATRIC HOSPITAL (submitted in 2019)
3PC-051
CIRCUIT TO PREPARE AND CONDITION ORAL HAZARDOUS MEDICINES (submitted in 2019)
3PC-050
IMPORTANCE OF COMPOUNDING IN THE PAEDIATRIC HOSPITAL PHARMACY (submitted in 2019)
3PC-049
IMIPENEM-CILASTATIN FORTIFIED EYE DROPS FOR THE TREATMENT OF CORNEAL ULCERS CAUSED BY: CONTACT LENSES. DEVELOPMENT AND CHARACTERISATION (submitted in 2019)
3PC-048
IMPORTANCE OF NON-STERILE FORMULATION IN A PAEDIATRIC HOSPITAL (submitted in 2019)
3PC-047
STUDY OF THE TRIGON DEPOT ALLERGY TEST (TRIAMCINOLONE AND EXCIPIENTS: CARBOXYMETHYLCELLULOSE, POLYSORBATE 80) DEVELOPED IN THE PHARMACY DEPARTMENT (submitted in 2019)
3PC-046
PARENTERAL NUTRITION ADMIXTURES: REVIEW OF THE MICROBIOLOGICAL SAMPLING PLAN (submitted in 2019)
3PC-045
IMPACT OF THE PREPARATION OF A CLINICAL SOLUTION OF RITUXIMAB 1.0 MG/ML ON THE PARTICULATES (AGGREGATION) MEASURED BY DYNAMIC LIGHT SCATTERING: SODIUM CHLORIDE AND GLUCOSE CONCENTRATION, AND AGITATION EFFECT (submitted in 2019)
3PC-044
IN USE PHYSICOCHEMICAL STABILITY OF PEMBROLIZUMAB UNDER THE DILUTION CONDITION REQUIRED FOR USE IN A DAY HOSPITAL (submitted in 2019)
3PC-043
HAZARDOUS DRUGS: IMPACT OF MEASURES FOR SAFE HANDLING (submitted in 2019)
3PC-042
THE SIGNIFICANCE OF PHARMACY PREPARATION IN PAEDIATRICS: MAKING INDIVIDUAL THERAPIES FOR CRITICALLY ILL CHILDREN POSSIBLE (submitted in 2019)
3PC-041
SURFACE CONTAMINATION WITH CYTOTOXIC DRUGS IN EUROPEAN HOSPITAL WARDS (submitted in 2019)
3PC-040
GALENIC VALIDATION OF A DEXAMETHASONE 0.01% MOUTHWASH SOLUTION TO PREVENT EVEROLIMUS RELATED STOMATITIS (submitted in 2019)
3PC-039
OPTIMISATION OF MIXING AN ORAL POWDER MIXTURE OF CODEINE PREPARED IN THE HOSPITAL PHARMACY FOR FILLING INTO HARD CAPSULES (submitted in 2019)
3PC-038
PHYSICOCHEMICAL STABILITY OF THE BEVACIZUMAB BIOSIMILAR, ABP 215, IN INTRAVENOUS BAGS AFTER PREPARATION AND STORAGE (submitted in 2019)
